Acute myeloid leukaemia (AML)

This study is looking at a type of treatment called intestinal microbiota transplant. It’s a way of encouraging more variety in gut bacteria.

This trial looked at an immunotherapy drug called magrolimab alone or with azacitidine for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS).

This study is assessing the value of prehabilitation for people with acute myeloid leukaemia and myelodysplastic syndrome.

This trial is comparing standard treatment with 2 newer combinations of treatment to prevent GvHD.

This trial is comparing venetoclax and azacitidine with azacitidine for acute myeloid leukaemia (AML).

This trial is comparing venetoclax and low dose cytarabine with intensive chemotherapy. It is for people with acute myeloid leukaemia aged 55 years and older.

This study is looking at how the COVID-19 vaccines affect the immune system of people with cancer and chronic illnesses.

This trial is for people with blood cancer that has come back or is getting worse despite treatment.

This trial is looking at new combinations of chemotherapy before a stem cell transplant to improve treatment for people with AML and MDS.

This trial is looking at a drug called azacitidine after a stem cell transplant for people who have acute myeloid leukaemia or high risk myelodysplasia.